Exosome Diagnostics Names New Director of Genetics Research
Posted on: Monday, 15 September 2008, 09:00 CDT
Exosome Diagnostics, a developer of proprietary genetics-based diagnostic tests with applications in oncology and endocrinology, has appointed Johan Skog as its new director of genetics research.
In this role, Dr Skog will oversee the research program that underlies the company's development of its blood-based diagnostics that can identify cancer-specific genetic mutations.
Dr Skog is the primary discoverer and inventor of Exosome Diagnostics's core technology that has been licensed exclusively to the company by Massachusetts General Hospital. Dr Skog has received his PhD specializing in gene therapy from Umea University in Sweden.
James McCullough, chairman and CEO of Exosome, said: "Dr Skog's discoveries are the foundation of our development program to capture diagnostic quantities of genetic mutations in blood. His expertise as the inventor of the technology of isolating genetic mutations from circulating exosomes for use as diagnostic and prognostic tools will enable the company to rapidly move forward on its first program, a blood-based diagnostic for brain cancer."
Source: Datamonitor
Related Articles
- Perlegen Out-Licenses Patented Technologies for Genetic Diagnostics
- Power3 Medical Products and the Princess Haya Biotechnology Center, Jordan University of Science and Technology, Collaborate in a Clinical Validation Study of the BC-SeraPro(TM) Breast Cancer Diagnostic Blood Test
- Perlegen Sciences Out-Licenses Intellectual Property for Genetic Diagnostics
- ParagonDx Forms Partnership With Iverson Genetic Diagnostics
- Iverson Genetic Diagnostics Offers FDA Cleared Warfarin Test
- Genetic Diagnostics Expert, Dr. Kavita Reddy, Joins CombiMatrix As Laboratory Director
- Mission Pharmacal Sells Gold Standard Kidney Stone Diagnostic Tests to Quest Diagnostics
- ICx Technologies and Siemens Medical Solutions Diagnostics Enter In Vitro Diagnostics Development and License Option Agreement
- Predictive Medicine, Pharmacogenomic Testing, and Prenatal Genetic Screening Support Growth of the Genetic Diagnostics Market
- Article Supports Use of Diagnostic Blood Tests for Allergies; Evidence Helps Boost Low Accuracy of Diagnosis Rates and Improve Patient Care
 |
 |
User Comments (0)
RSS Feeds